Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Physiol ; 602(7): 1427-1442, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38468384

RESUMEN

Fibroblast growth factor-2 (FGF2) is involved in the regulation of affective behaviour and shows antidepressant effects through the Akt and extracellular signal regulated kinase (ERK) 1/2 pathways. Nudix hydrolase 6 (NUDT6) protein is encoded from FGF2 gene's antisense strand and its role in the regulation of affective behaviour is unknown. Here, we overexpressed NUDT6 in the hippocampus and investigated its behavioural effects and the underlying molecular mechanisms affecting the behaviour. We showed that increasing hippocampal NUDT6 results in depression-like behaviour in rats without changing FGF2 levels or activating its downstream effectors, Akt and ERK1/2. Instead, NUDT6 acted by inducing inflammatory signalling, specifically by increasing S100 calcium binding protein A9 (S100A9) levels, activating nuclear factor-kappa B-p65 (NF-κB-p65), and elevating microglia numbers along with a reduction in neurogenesis. Our results suggest that NUDT6 could play a role in major depression by inducing a proinflammatory state. This is the first report of an antisense protein acting through a different mechanism of action than regulation of its sense protein. The opposite effects of NUDT6 and FGF2 on depression-like behaviour may serve as a mechanism to fine-tune affective behaviour. Our findings open up new venues for studying the differential regulation and functional interactions of sense and antisense proteins in neural function and behaviour, as well as in neuropsychiatric disorders. KEY POINTS: Hippocampal overexpression of nudix hydrolase 6 (NUDT6), the antisense protein of fibroblast growth factor-2 (FGF2), increases depression-like behaviour in rats. Hippocampal NUDT6 overexpression triggers a neuroinflammatory cascade by increasing S100 calcium binding proteinA9 (S100A9) expression and nuclear NF-κB-p65 translocation in neurons, in addition to microglial recruitment and activation. Hippocampal NUDT6 overexpression suppresses neurogenesis. NUDT6 exerts its actions without altering the levels or downstream signalling pathways of FGF2.


Asunto(s)
Depresión , Factor 2 de Crecimiento de Fibroblastos , FN-kappa B , Animales , Ratas , Factor 2 de Crecimiento de Fibroblastos/genética , Inflamación/genética , Neurogénesis/genética , FN-kappa B/metabolismo , FN-kappa B/farmacología , Proteínas Proto-Oncogénicas c-akt , Factores de Crecimiento de Fibroblastos/genética , Factores de Crecimiento de Fibroblastos/metabolismo , Depresión/genética , Depresión/metabolismo
2.
J Headache Pain ; 25(1): 120, 2024 Jul 24.
Artículo en Inglés | MEDLINE | ID: mdl-39044141

RESUMEN

Migraine is a neurological disorder characterized by episodes of severe headache. Cortical spreading depression (CSD), the electrophysiological equivalent of migraine aura, results in opening of pannexin 1 megachannels that release ATP and triggers parenchymal neuroinflammatory signaling cascade in the cortex. Migraine symptoms suggesting subcortical dysfunction bring subcortical spread of CSD under the light. Here, we investigated the role of purinergic P2X7 receptors on the subcortical spread of CSD and its consequent neuroinflammation using a potent and selective P2X7R antagonist, JNJ-47965567. P2X7R antagonism had no effect on the CSD threshold and characteristics but increased the latency to hypothalamic voltage deflection following CSD suggesting that ATP acts as a mediator in the subcortical spread. P2X7R antagonism also prevented cortical and subcortical neuronal activation following CSD, revealed by bilateral decrease in c-fos positive neuron count, and halted CSD-induced neuroinflammation revealed by decreased neuronal HMGB1 release and decreased nuclear translocation of NF-kappa B-p65 in astrocytes. In conclusion, our data suggest that P2X7R plays a role in CSD-induced neuroinflammation, subcortical spread of CSD and CSD-induced neuronal activation hence can be a potential target.


Asunto(s)
Depresión de Propagación Cortical , Enfermedades Neuroinflamatorias , Antagonistas del Receptor Purinérgico P2X , Receptores Purinérgicos P2X7 , Depresión de Propagación Cortical/efectos de los fármacos , Depresión de Propagación Cortical/fisiología , Animales , Antagonistas del Receptor Purinérgico P2X/farmacología , Masculino , Receptores Purinérgicos P2X7/metabolismo , Receptores Purinérgicos P2X7/efectos de los fármacos , Optogenética , Ratones , Trastornos Migrañosos/fisiopatología , Trastornos Migrañosos/metabolismo , Trastornos Migrañosos/tratamiento farmacológico , Neuronas/efectos de los fármacos , Ratones Endogámicos C57BL , Niacinamida/análogos & derivados , Piperazinas
3.
STAR Protoc ; 5(2): 103089, 2024 Jun 21.
Artículo en Inglés | MEDLINE | ID: mdl-38795356

RESUMEN

Generating stable human embryonic stem cells (hESCs) with targeted genetic mutations allows for the interrogation of protein function in numerous cellular contexts while maintaining a relatively high degree of isogenicity. We describe a step-by-step protocol for generating knockout hESC lines with mutations in genes involved in synaptic transmission using CRISPR-Cas9. We describe steps for gRNA design, cloning, stem cell transfection, and clone isolation. We then detail procedures for gene knockout validation and differentiation of stem cells into functional induced neurons.


Asunto(s)
Sistemas CRISPR-Cas , Edición Génica , Células Madre Embrionarias Humanas , Neuronas , Humanos , Sistemas CRISPR-Cas/genética , Células Madre Embrionarias Humanas/citología , Células Madre Embrionarias Humanas/metabolismo , Neuronas/citología , Neuronas/metabolismo , Edición Génica/métodos , Diferenciación Celular/genética , Técnicas de Inactivación de Genes/métodos , ARN Guía de Sistemas CRISPR-Cas/genética , Sinapsis/metabolismo , Sinapsis/genética
4.
Front Synaptic Neurosci ; 15: 1148957, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37066095

RESUMEN

Synaptic neurotransmitter release is an evolutionarily conserved process that mediates rapid information transfer between neurons as well as several peripheral tissues. Release of neurotransmitters are ensured by successive events such as synaptic vesicle docking and priming that prepare synaptic vesicles for rapid fusion. These events are orchestrated by interaction of different presynaptic proteins and are regulated by presynaptic calcium. Recent studies have identified various mutations in different components of neurotransmitter release machinery resulting in aberrant neurotransmitter release, which underlie a wide spectrum of psychiatric and neurological symptoms. Here, we review how these genetic alterations in different components of the core neurotransmitter release machinery affect the information transfer between neurons and how aberrant synaptic release affects nervous system function.

5.
Cell Rep ; 42(2): 112042, 2023 02 28.
Artículo en Inglés | MEDLINE | ID: mdl-36701235

RESUMEN

Rapid release of neurotransmitters in synchrony with action potentials is considered a key hardwired property of synapses. Here, in glutamatergic synapses formed between induced human neurons, we show that action potential-dependent neurotransmitter release becomes progressively desynchronized as synapses mature and age. In this solely excitatory network, the emergence of NMDAR-mediated transmission elicits endoplasmic reticulum (ER) stress leading to downregulation of key presynaptic molecules, synaptotagmin-1 and cysteine string protein α, that synchronize neurotransmitter release. The emergence of asynchronous release with neuronal maturity and subsequent aging is maintained by the high-affinity Ca2+ sensor synaptotagmin-7 and suppressed by the introduction of GABAergic transmission into the network, inhibition of NMDARs, and ER stress. These results suggest that long-term disruption of excitation-inhibition balance affects the synchrony of excitatory neurotransmission in human synapses.


Asunto(s)
Neuronas , Transmisión Sináptica , Humanos , Neuronas/metabolismo , Transmisión Sináptica/fisiología , Sinapsis/metabolismo , Neurotransmisores/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Envejecimiento , Calcio/metabolismo
6.
Cell Calcium ; 105: 102611, 2022 07.
Artículo en Inglés | MEDLINE | ID: mdl-35709660

RESUMEN

Neurotransmitter activation of G protein-coupled receptors differentially modulate neural information transfer and activity. A recent study by Tian and colleagues have identified that activation of two ion channels, Transient Receptor Potential Channel 4 (TRPC4) and G protein-coupled inward rectifier K+ (GIRK) modulate action potential firing upon co-activation Gi/o and Gq by co-released neurotransmitters. Here, we discuss these results suggesting a nonlinear interaction of coincidental Gi/o and Gq/11 activation that yields discernible neuronal activity patterns during neurotransmission.


Asunto(s)
Canales de Potasio Rectificados Internamente Asociados a la Proteína G , Proteínas de Unión al GTP , Potenciales de Acción , Proteínas de Unión al GTP/metabolismo , Neurotransmisores , Receptores Acoplados a Proteínas G
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA